ASHLEY BOLER: Open Payments
NPI 1548641145 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 19 payments from 10 companies in 2025. Trend: 2023 $362 · 2024 $153 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $131 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Stryker Corporation | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $18 |
Products named: Wegovy, AMVUTTRA, Kerendia, VERQUVO, CLOTTRIEVER BOLD CATHETER, UPTRAVI, JARDIANCE, LifeVest.
Industry payments across AL — which companies pay providers there.
